They looked at the whole-genome sequences of people who had their DNA read as part of the project. Whole-genome sequencing is ...

To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...

An AI tool analyzes biopsy images. To determine the type and severity of cancer, pathologists typically examine thin slices ...

Researchers used artificial intelligence to predict the activity of thousands of genes in tumors based on routinely collected ...

Researchers have combined two gene editing methods. This enables them to quickly investigate the significance of many genetic mutations involved in the development and treatment of cancer.

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

A breakthrough tool called Helicase-Assisted Continuous Editing (HACE) allows scientists to create precise genetic mutations ...

To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a microscope.

Concurrent DNA and RNA sequencing revealed 15.3% more patients with actionable variants than DNA sequencing alone.

More than half of midlands-based cancer patients whose genomes were successfully sequenced through the 100,000 Genomes ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

With whole-genome sequencing and computational tools, the researchers identified genetic mutations and structural variations ...